Japan Pharmas Eye Asia's Growing Middle-Income Market For Sales
This article was originally published in PharmAsia News
Executive Summary
At least two Japanese pharmaceutical companies are betting on a growing population of middle-income people elsewhere in Asia to drive their export businesses